Crescendo Bioscience

Operator of a molecular diagnostics company focused in rheumatology. The company is focused on developing and commercializing quantitative blood tests for rheumatoid arthritis (RA), including Vectra DA, a standardized multi-biomarker blood test validated to assess disease activity in RA, enabling effective management of autoimmune and inflammatory diseases by providing quantitative, objective molecular tests and disease information services to rheumatologists and patients.

Kleiner Perkins

🏥 Healthcare